Cerenome, Inc CNSY

US Biotechnology

$0.68 ▲ +19.01% (+$0.11)

⬆️ Above Yest. High 📅 Earnings This Week

Open $0.56

Prev Close $0.57

Day Range $0.43 – $0.69

52W Range $0.57 – $4.25

Market Cap $4.32M

Beta 3.55

EPS (TTM) $-4.42

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-08-09
Shares Out.	7,590,000
Website	cerenome.com ↗
Phone	13026365401
Employees	28

About Cerenome, Inc

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Cerenome, Inc is a publicly traded company under the ticker symbol CNSY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.